New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Kura Oncology, Inc.
KURA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 07 Nov 2024

1B

Biotechnology

Next Earning date - 07 Nov 2024

17.51USD
Shape-0.27 ( -1.52%)
favorite-chart

Relative Strenght

84
favorite-chart

Volume Buzz

5%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

28%

Quote Panel

Shape
Updated October 26, 2024
1W -1.02 % 1M -10.25 % 3M -16.01 % 1Y 128.72 %

Key Metrics

Shape
  • Market Cap

    1.34B


  • Shares Outstanding

    76.63M


  • Share in Float

    64.93M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    17.51


  • Average Volume

    541409


  • Beta

    0.835


  • Range

    7.52-24.17


  • Industry

    Biotechnology


  • Website

    https://kuraoncology.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1081.03x

P/S Ratio

3.33x

P/B Ratio

0.0

Debt/Equity

-14311.0%

Net Margin

$-2.2

EPS

How KURA compares to sector?

P/E Ratio

Relative Strength

Shape

KURA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

ShapeNaN%

2025-Revenue

$2.63

Shape-347%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

initialise

Previous: Not converted

2024-10-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.53
vs -0.50

Q4.22

arrow
arrow

N/A

-0.49
vs -0.49

Q1.23

arrow
arrow

N/A

-0.50
vs -0.49

Q2.23

arrow
arrow

N/A

-0.53
vs -0.52

Q3.23

arrow
arrow

N/A

-0.50
vs -0.53

Q4.23

arrow
arrow

N/A

-0.55
vs -0.49

Q1.24

arrow
arrow

N/A

-0.59
vs -0.50

Q2.24

arrow
arrow

N/A

-0.59
vs -0.53

Q3.24

arrow
arrow

N/A

-0.63
vs -0.50

Q4.24

arrow
arrow

N/A

-0.64
vs -0.55

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.3M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.08

Q4.22

arrow
arrow

+6%

0.06
vs -0.08

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

+6%

0.06
vs 0.05

Q3.23

arrow
arrow

-9%

-0.09
vs 0.06

Q4.23

arrow
arrow

-11%

-0.11
vs -0.09

Q1.24

arrow
arrow

-10%

-0.10
vs -0.11

Q2.24

arrow
arrow

-11%

-0.11
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

150

150
vs 149

1%

Q4.22

arrow
arrow

145

145
vs 150

-3%

Q1.23

arrow
arrow

144

144
vs 145

-1%

Q2.23

arrow
arrow

154

154
vs 144

7%

Q3.23

arrow
arrow

134

134
vs 154

-13%

Q4.23

arrow
arrow

142

142
vs 134

6%

Q1.24

arrow
arrow

171

171
vs 142

20%

Q2.24

arrow
arrow

179

179
vs 171

5%

Earnings Growth

Latest News